X. Gu

发表

Matrix metalloproteinase 9 activity in urine of patients at risk for premature delivery.

M. Agrez, X. Gu, W. Giles, 1999, American journal of obstetrics and gynecology.

First-in-human study of DS-6051b in patients (pts) with advanced solid tumors (AST) conducted in the US.

P. Jänne, A. Shaw, S. Ou, 2018 .

Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs)

W. Tap, J. Healey, H. Gelderblom, 2019, Annals of Oncology.